LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 72.24 | 21.74 | 1230 | 6162 | 0.1996 | 0.6411 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 72.24 | 21.74 | 1250 | 6162 | 0.2029 | 0.6443 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 74.21 | 21.74 | 1270 | 6235 | 0.2037 | 0.6458 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 74.21 | 21.74 | 1282 | 6235 | 0.2056 | 0.6477 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 74.21 | 21.74 | 1243 | 6235 | 0.1993 | 0.6415 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 74.21 | 21.74 | 1262 | 6235 | 0.2024 | 0.6445 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 76.18 | 21.74 | 1273 | 6114 | 0.2082 | 0.6492 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 76.18 | 21.74 | 1284 | 6114 | 0.2100 | 0.6509 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 76.18 | 21.74 | 1240 | 6114 | 0.2028 | 0.6438 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 76.18 | 21.74 | 1255 | 6114 | 0.2053 | 0.6463 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 78.15 | 21.74 | 1267 | 6167 | 0.2054 | 0.6469 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 78.15 | 21.74 | 1277 | 6167 | 0.2071 | 0.6485 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 78.15 | 21.74 | 1231 | 6167 | 0.1996 | 0.6411 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 78.15 | 21.74 | 1252 | 6167 | 0.2030 | 0.6445 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 80.12 | 21.74 | 1298 | 6211 | 0.2090 | 0.6508 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 80.12 | 21.74 | 1309 | 6211 | 0.2107 | 0.6525 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 80.12 | 21.74 | 1268 | 6211 | 0.2041 | 0.6461 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 80.12 | 21.74 | 1286 | 6211 | 0.2070 | 0.6489 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 82.09 | 21.74 | 1296 | 6201 | 0.2090 | 0.6507 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 82.09 | 21.74 | 1302 | 6201 | 0.2100 | 0.6517 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 82.09 | 21.74 | 1280 | 6201 | 0.2064 | 0.6482 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 82.09 | 21.74 | 1304 | 6201 | 0.2103 | 0.6520 | MN20160310_N01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 84.06 | 21.74 | 1291 | 6152 | 0.2099 | 0.6511 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 84.06 | 21.74 | 1300 | 6152 | 0.2113 | 0.6525 | MN20160310_N01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 84.06 | 21.74 | 1240 | 6152 | 0.2016 | 0.6430 | MN20160310_N01 | L05 |